JP2022501342A5 - - Google Patents
Info
- Publication number
- JP2022501342A5 JP2022501342A5 JP2021514532A JP2021514532A JP2022501342A5 JP 2022501342 A5 JP2022501342 A5 JP 2022501342A5 JP 2021514532 A JP2021514532 A JP 2021514532A JP 2021514532 A JP2021514532 A JP 2021514532A JP 2022501342 A5 JP2022501342 A5 JP 2022501342A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- alkyl
- pharmaceutically acceptable
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862732735P | 2018-09-18 | 2018-09-18 | |
| US62/732,735 | 2018-09-18 | ||
| PCT/US2019/051514 WO2020061046A1 (en) | 2018-09-18 | 2019-09-17 | Somatostatin modulators and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022501342A JP2022501342A (ja) | 2022-01-06 |
| JP2022501342A5 true JP2022501342A5 (enExample) | 2022-09-27 |
| JP7431813B2 JP7431813B2 (ja) | 2024-02-15 |
Family
ID=69772634
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021514532A Active JP7431813B2 (ja) | 2018-09-18 | 2019-09-17 | ソマトスタチンモジュレーターとその使用 |
Country Status (17)
| Country | Link |
|---|---|
| US (4) | US10696689B2 (enExample) |
| EP (2) | EP4548974A3 (enExample) |
| JP (1) | JP7431813B2 (enExample) |
| AR (1) | AR116424A1 (enExample) |
| DK (1) | DK3853218T3 (enExample) |
| ES (1) | ES3022912T3 (enExample) |
| FI (1) | FI3853218T3 (enExample) |
| HR (1) | HRP20250425T1 (enExample) |
| HU (1) | HUE071203T2 (enExample) |
| LT (1) | LT3853218T (enExample) |
| PL (1) | PL3853218T3 (enExample) |
| PT (1) | PT3853218T (enExample) |
| RS (1) | RS66720B1 (enExample) |
| SI (1) | SI3853218T1 (enExample) |
| SM (1) | SMT202500155T1 (enExample) |
| TW (1) | TWI852944B (enExample) |
| WO (1) | WO2020061046A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL264178B2 (en) | 2016-07-14 | 2024-05-01 | Crinetics Pharmaceuticals Inc | Somatostatin modulators and uses thereof |
| EP3596062A4 (en) | 2017-03-16 | 2020-08-26 | Crinetics Pharmaceuticals, Inc. | SOMATOSTATIN MODULATORS AND THEIR USES |
| MA51840A (fr) | 2018-02-12 | 2021-05-19 | Crinetics Pharmaceuticals Inc | Modulateurs de somatostatine et leurs utilisations |
| SMT202500155T1 (it) | 2018-09-18 | 2025-05-12 | Crinetics Pharmaceuticals Inc | Modulatori della somatostatina e loro usi |
| TWI841768B (zh) | 2019-08-14 | 2024-05-11 | 美商克林提克斯醫藥股份有限公司 | 非肽生長抑制素(somatostatin)5型受體激動劑及其用途 |
| CA3191084A1 (en) | 2020-09-09 | 2022-03-17 | Gerald Burke | Formulations of a somatostatin modulator |
| JP2024506715A (ja) | 2021-02-17 | 2024-02-14 | クリネティックス ファーマシューティカルズ，インク． | ソマトスタチンモジュレーターの結晶形態 |
| TW202440164A (zh) * | 2022-12-13 | 2024-10-16 | 美商克林提克斯醫藥股份有限公司 | 生長抑素亞型-2受體（sst2r）靶向治療劑及其用途 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6127343A (en) * | 1996-05-14 | 2000-10-03 | Novo Nordisk A/S | Somatostatin agonists and antagonists |
| US6025372A (en) * | 1997-04-04 | 2000-02-15 | Merck & Co., Inc. | Somatostatin agonists |
| FR2802206B1 (fr) | 1999-12-14 | 2005-04-22 | Sod Conseils Rech Applic | Derives de 4-aminopiperidine et leur utilisation en tant que medicament |
| US20060281764A1 (en) | 2005-06-10 | 2006-12-14 | Gaul Michael D | Aminopyrimidines as kinase modulators |
| AU2007309708A1 (en) | 2006-03-13 | 2008-05-02 | Merck Sharp & Dohme Corp. | Somatostatin agonists |
| WO2008019967A2 (en) | 2006-08-15 | 2008-02-21 | F. Hoffmann-La Roche Ag | Phenyl, pyridine and quinoline derivatives |
| WO2009051705A1 (en) | 2007-10-18 | 2009-04-23 | Merck & Co., Inc. | Substituted 1,2,4-oxadiazoles and analogs thereof as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases |
| JP2011526294A (ja) | 2008-06-25 | 2011-10-06 | エンビボ ファーマシューティカルズ インコーポレイテッド | ホスホジエステラーゼ１０阻害剤としての二置換フェニル化合物 |
| GB0818241D0 (en) | 2008-10-06 | 2008-11-12 | Cancer Res Technology | Compounds and their use |
| JP2013503846A (ja) | 2009-09-01 | 2013-02-04 | ファイザー・インク | ベンズイミダゾール誘導体 |
| AU2011256444B2 (en) * | 2010-05-18 | 2014-07-10 | Merck Sharp & Dohme Corp. | Spiro isoxazoline compounds as SSTR5 antagonists |
| GB201008290D0 (en) | 2010-05-18 | 2010-06-30 | Syngenta Ltd | Chemical compounds |
| WO2014007228A1 (ja) * | 2012-07-03 | 2014-01-09 | 小野薬品工業株式会社 | ソマトスタチン受容体作動活性を有する化合物およびその医薬用途 |
| US9643951B2 (en) | 2013-09-30 | 2017-05-09 | Ono Pharmaceutical Co., Ltd. | Compound having somatostatin receptor agonistic activity and pharmaceutical use thereof |
| ES2675504T3 (es) | 2013-10-02 | 2018-07-11 | Kuraray Co., Ltd. | Composición de resina, lámina de múltiples capas, material de envasado y recipiente |
| IL264178B2 (en) | 2016-07-14 | 2024-05-01 | Crinetics Pharmaceuticals Inc | Somatostatin modulators and uses thereof |
| JP6838387B2 (ja) * | 2016-12-21 | 2021-03-03 | トヨタ紡織株式会社 | 内装部品の取付構造 |
| AU2018219644A1 (en) * | 2017-02-08 | 2019-08-29 | Ono Pharmaceutical Co., Ltd. | Compound having somatostatin receptor agonistic activity and pharmaceutical use thereof |
| EP3596062A4 (en) | 2017-03-16 | 2020-08-26 | Crinetics Pharmaceuticals, Inc. | SOMATOSTATIN MODULATORS AND THEIR USES |
| EP3658560A4 (en) | 2017-07-25 | 2021-01-06 | Crinetics Pharmaceuticals, Inc. | SOMATOSTAT IN MODULATORS AND USES THEREOF |
| MA51840A (fr) | 2018-02-12 | 2021-05-19 | Crinetics Pharmaceuticals Inc | Modulateurs de somatostatine et leurs utilisations |
| SMT202500155T1 (it) | 2018-09-18 | 2025-05-12 | Crinetics Pharmaceuticals Inc | Modulatori della somatostatina e loro usi |
| TWI841768B (zh) | 2019-08-14 | 2024-05-11 | 美商克林提克斯醫藥股份有限公司 | 非肽生長抑制素(somatostatin)5型受體激動劑及其用途 |
-
2019
- 2019-09-17 SM SM20250155T patent/SMT202500155T1/it unknown
- 2019-09-17 TW TW108133468A patent/TWI852944B/zh active
- 2019-09-17 WO PCT/US2019/051514 patent/WO2020061046A1/en not_active Ceased
- 2019-09-17 PL PL19863395.0T patent/PL3853218T3/pl unknown
- 2019-09-17 AR ARP190102640A patent/AR116424A1/es unknown
- 2019-09-17 HU HUE19863395A patent/HUE071203T2/hu unknown
- 2019-09-17 HR HRP20250425TT patent/HRP20250425T1/hr unknown
- 2019-09-17 US US16/572,921 patent/US10696689B2/en active Active
- 2019-09-17 LT LTEPPCT/US2019/051514T patent/LT3853218T/lt unknown
- 2019-09-17 FI FIEP19863395.0T patent/FI3853218T3/fi active
- 2019-09-17 PT PT198633950T patent/PT3853218T/pt unknown
- 2019-09-17 SI SI201930927T patent/SI3853218T1/sl unknown
- 2019-09-17 RS RS20250348A patent/RS66720B1/sr unknown
- 2019-09-17 DK DK19863395.0T patent/DK3853218T3/da active
- 2019-09-17 EP EP25151398.2A patent/EP4548974A3/en active Pending
- 2019-09-17 ES ES19863395T patent/ES3022912T3/es active Active
- 2019-09-17 EP EP19863395.0A patent/EP3853218B1/en active Active
- 2019-09-17 JP JP2021514532A patent/JP7431813B2/ja active Active
-
2020
- 2020-05-19 US US16/877,947 patent/US11186590B2/en active Active
-
2021
- 2021-10-26 US US17/511,326 patent/US20220048924A1/en not_active Abandoned
-
2022
- 2022-04-06 US US17/714,825 patent/US11834462B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022501342A5 (enExample) | ||
| JP2024528036A5 (enExample) | ||
| FI3853218T3 (fi) | Somatostatiinin modulaattoreita ja niiden käyttöjä | |
| JP2016164184A5 (enExample) | ||
| JP2023514872A5 (enExample) | ||
| JP2007531744A5 (enExample) | ||
| JP2019031560A5 (enExample) | ||
| JP2020511452A5 (enExample) | ||
| RU2011121567A (ru) | Изоиндолиновые соединения для применения при лечении рака | |
| JP2016512844A5 (enExample) | ||
| JP4324791B2 (ja) | ２−アシルアミノチアゾール誘導体又はその塩 | |
| FI3759088T3 (fi) | Triatsiinijohdannaiset neurotrofiineihin liittyvien sairauksien hoitamiseksi | |
| HRP20170112T1 (hr) | Supstituirani spojevi piridin-2-karboksamida kao kinazni inhibitori signalne regulacije apoptoze | |
| JP2013517264A5 (enExample) | ||
| RU2018138047A (ru) | Гетероциклические вещества - агонисты gpr119 | |
| RU2018113430A (ru) | Производные l-фенилпирролидин-2-она в качестве ингибиторов perk | |
| JP2013530240A5 (enExample) | ||
| JP2003502272A5 (enExample) | ||
| JP2004502670A5 (enExample) | ||
| RU2010116352A (ru) | Производные 1,1,1-трифтор-2-гидрокси-3-фенилпропана | |
| CA2503117A1 (en) | Substituted 4-alkoxyoxazol derivatives as ppar agonists | |
| RU2016141647A (ru) | ИНГИБИТОРЫ TrkA КИНАЗЫ, ОСНОВАННЫЕ НА НИХ КОМПОЗИЦИИ И СПОСОБЫ | |
| JP2017512786A5 (enExample) | ||
| JP2006506380A5 (enExample) | ||
| RU2014141674A (ru) | 3,5-диаминопиразоловые ингибиторы киназы |